ARCHIMEDlife News
-
New testing options for Cerebrotendinous Xanthomatosis (CTX)
About CTX: CTX (cerebrotendinous xanthomatosis) is a rare and serious disease of bile acid metabolism with an estimated incidence of about 1:50,000. The disease is… Read more
-
Our new look: Updated website design, more information
ARCHIMEDlife News December 21, 2020We are pleased to announce the release of our updated and streamlined website. You can find all the relevant information on our available diagnostic services… Read more
-
Staying focused on Rare Diseases
At ARCHIMEDlife, our focus continues to be on Rare Diseases and special diagnostics. Since March 2020, COVID-19 has challenged us all both personally and professionally.… Read more
-
Advanced diagnostics for Mucopolysaccharidoses
Mucopolysaccharidoses (MPSs) are a group of inherited lysosomal storage disorders affecting lysosomal metabolism. MPSs result in the accumulation of glycosaminoglycans in the body and can… Read more
-
OPEN LETTER – We stay open for you and your patients – Please read
We stay open for you and your patients! We used the last days to prepare us to continue our work and services on the highest… Read more
-
amedes and ARCHIMEDlife – a new strong international alliance
ARCHIMEDlife News January 17, 2020ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and medical-diagnostic services for patients, physicians and… Read more